{
    "Title": "A single dose of antibody-drug conjugate cures a stage 1 model of African trypanosomiasis",
    "URL": "https://doi.org/10.1371/journal.pntd.0007373",
    "Published": "May 23, 2019",
    "Subject_Areas": [
        "Trypanosoma",
        "Mouse models",
        "Toxins",
        "Trypanosoma brucei",
        "Animal models of infection",
        "Trypanosoma brucei gambiense",
        "Parasitic diseases",
        "Antibodies"
    ],
    "Authors": {
        "Paula MacGregor": [
            "Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom"
        ],
        "Andrea L. Gonzalez-Munoz": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Fatoumatta Jobe": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Martin C. Taylor": [
            "London School of Hygiene and Tropical Medicine, London, United Kingdom"
        ],
        "Steven Rust": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Alan M. Sandercock": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Olivia J. S. Macleod": [
            "Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom"
        ],
        "Katrien Van Bocxlaer": [
            "London School of Hygiene and Tropical Medicine, London, United Kingdom"
        ],
        "Amanda F. Francisco": [
            "London School of Hygiene and Tropical Medicine, London, United Kingdom"
        ],
        "Francois Dâ€™Hooge": [
            "Spirogen Ltd, London, United Kingdom"
        ],
        "Arnaud Tiberghien": [
            "Spirogen Ltd, London, United Kingdom"
        ],
        "Conor S. Barry": [
            "Spirogen Ltd, London, United Kingdom"
        ],
        "Philip Howard": [
            "Spirogen Ltd, London, United Kingdom"
        ],
        "Matthew K. Higgins": [
            "Department of Biochemistry, University of Oxford, Oxford, United Kingdom"
        ],
        "Tristan J. Vaughan": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Ralph Minter": [
            "Department of Antibody Discovery and Protein Engineering, Medimmune, Cambridge, United Kingdom"
        ],
        "Mark Carrington": [
            "Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom"
        ]
    }
}